Your browser doesn't support javascript.
loading
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Burris, Howard A; Chan, Arlene; Bardia, Aditya; Thaddeus Beck, J; Sohn, Joohyuk; Neven, Patrick; Tripathy, Debu; Im, Seock-Ah; Chia, Stephen; Esteva, Francisco J; Hart, Lowell; Zarate, Juan Pablo; Ridolfi, Antonia; Lorenc, Karen Rodriguez; Yardley, Denise A.
Affiliation
  • Burris HA; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA. Howard.Burris@SarahCannon.com.
  • Chan A; Breast Cancer Research Centre WA and Curtin University, Perth, Australia.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Thaddeus Beck J; Highlands Oncology Group, Fayetteville, AR, USA.
  • Sohn J; Severance Hospital, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea.
  • Neven P; Multidisciplinary Breast Centre, Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Chia S; BC Cancer Agency, Vancouver, BC, Canada.
  • Esteva FJ; NYU Langone Health, New York, NY, USA.
  • Hart L; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, FL, USA.
  • Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Ridolfi A; Novartis Pharmaceuticals Corporation, Paris, France.
  • Lorenc KR; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Yardley DA; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.
Br J Cancer ; 125(5): 679-686, 2021 08.
Article in En | MEDLINE | ID: mdl-34158598
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Purines / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents, Hormonal / Aminopyridines Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Purines / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents, Hormonal / Aminopyridines Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2021 Type: Article Affiliation country: United States